Akcea Therapeutics Receives Orphan Designation in Europe for Volanesorsen for the Treatment of Familial Partial Lipodystrophy (FPL)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/12/2026

1. SKHY
2. USO
3. SPY
4. META
5. DAL
6. PEP
7. SKHYV
8. ALP
9. GTM
10. NVDA

Go back to Akcea Therapeutics Receives Orphan Designation in Europe for Volanesorsen for the Treatment of Familial Partial Lipodystrophy (FPL)
(NASDAQ: IONS) Delayed: 58.25 -6.02 (9.37%)
Previous Close $64.27    52 Week High $62.68 
Open $64.27    52 Week Low $19.59 
Day High $64.44    P/E N/A 
Day Low $58.20    EPS $0.00 
Volume 11,605,901